DON'T MISS : Talking Africa New Podcast – Ethiopia/Egypt: tension spikes despite Dam talks

Coronavirus: DRC doctor says clinical trials can begin using artemisia

In depth
This article is part of the dossier: Corona Chronicles: 18 May – 22 May

By Stanis Bujakera Tshiamala
Posted on Wednesday, 20 May 2020 09:55

Jérôme Munyangi, the Congolese pro-artemisia doctor (right), during his meeting with President Félix Tshisekedi, May 12 2020 © DR : DRC presidency

Félix Tshisekedi received Jérôme Munyangi, who had just returned from living in exile in France. We had a chance to interview the Congolese doctor and researcher who advocates using artemisia to combat the coronavirus.

Jérôme Munyangi was met with pomp and circumstance. Freshly arrived in Kinshasa on 7 May after leaving his country in a hurry back in March 2019, considering himself “persecuted” in the Democratic Republic of Congo for having promoted artemisia as an antimalarial treatment, this time around the doctor travelled in “a jet with a presidential security detail”, as he delightfully recounted during an appearance on Radio-Télévision Nationale Congolaise, the country’s national broadcaster.

One week after his return, he was received by none other than President Félix Tshisekedi himself. In the presence of the president, he gave an overview of his research on the effects of artemisia on malaria and advocated for the plant to be fully integrated into “research on an African solution” to the coronavirus.

On Wednesday, 13 May, the young 36-year-old doctor agreed to be interviewed by Jeune Afrique at the headquarters of the task force responsible for informing Tshisekedi on developments relating to the COVID-19 pandemic. A sign of the attention the president is paying to the researcher’s opinion, Tina Salama, Tshisekedi’s deputy spokesperson, served as the go-between to organise the meeting.

We have nothing to lose by trying to put Congolese and, more broadly, African scientists to work.

During all of his trips, the doctor, who maintains that he has received threats from drug resellers working in conjunction with Indian and Chinese pharmaceutical firms, is under the protection of a presidential security detail.

Jeune Afrique: You’ve returned to your home country after being gone for more than a year, a period during which you claimed to have been subject to persecution and threats in the DRC. Are you still afraid that you are at risk?

Jérôme Munyangi: Before agreeing to leave Paris, the first condition I laid down was that my safety be ensured. And it is. Today, I feel safe. And, to paraphrase the president of the Democratic Republic of Congo, there’s no need to dig up the past when you agree to return home. I have been very well received. The president invited me here… now I think it’s time to try to get to work in earnest to help combat the diseases impacting the DRC.

Who put you into touch with Tshisekedi?

Dr. Roger Kamba, the president’s adviser on universal health coverage, and Alexis Kayembe, his special adviser on infrastructure, contacted me on his behalf to organise my return to the country. Talks, primarily with La Maison de l’Artemisia, lasted two weeks.

What is your role within the president’s task force?

My role within the task force is related to research. The goal is to make our contribution to the various African solutions already in existence or currently under development.

What are your thoughts on the pandemic’s progression in the DRC? Were enough measures taken?

It’s exceedingly difficult to predict with certainty what’s going to happen, even when relying on epidemiological models. This was even the case in countries like France, where, at the outset, people were saying that the country wouldn’t be impacted. We all saw what happened afterwards.

Given the circumstances, the measures taken – even though the resources mobilised are perhaps insufficient – have helped stem the spread. While the responsible actions of the authorities certainly matter, those of the population do too.

Did you take part in developing Covid-Organics, the remedy promoted by the President of Madagascar, Andry Rajoelina?

I work for an NGO called La Maison de l’Artemisia France and the organisation contacted the authorities in numerous African countries, including Madagascar, which was the first to agree to integrate the plant into the combat against COVID-19. As head of clinical and medical research at Fondation Terra Artemisia France, I participated in this process.

READ MORE: Coronavirus: Madagascar’s ‘Covid-Organics’ born from local tradition

What do you think needs to be done to stop the spread of the coronavirus in the DRC?

To start, people need to comply with preventative hygiene practices and the measures implemented by the government. We also need to consider ways in which we can draw on our own scientists and solutions, and conduct clinical trials on the latter.

Take, for instance, hydroxychloroquine: despite the controversy it sparked, someone had the courage to defend it, and it has helped certain patients. We have nothing to lose by trying to put Congolese and, more broadly, African scientists to work.

READ MORE: Coronavirus: Rajoelina’s ‘remedy’ flows freely in Madagascar

We’ve come up with a solution which entails working towards conducting a clinical trial with artemisia. We’ve made proposals regarding this work to the African Union and the WHO. We have a coherent, ready-to-use protocol.

The same as that in effect in Madagascar?

No, Madagascar doesn’t have a clinical protocol. The solution known under the name Covid-Organics is an herbal tea containing artemisia and another medicinal plant. It’s a solution. What we’re proposing is a protocol, with a plan that complies with clinical research standards. Today, we’re ready to start the testing and clinical trial phase, which will help us determine whether or not the protocol can treat people diagnosed with COVID-19.

READ MORE: Coronavirus: the miracle remedy touted by Madagascar’s Rajoelina

When will the clinical trial begin? And how many patients will be involved?

That’s up to the authorities to decide. We can quickly begin a trial with 20 to 40 patients. Within two weeks, we’ll have the results.

Also in this in Depth:

Hopping to another crisis: Locusts and coronavirus in East Africa

As if taken from the playbook of an infuriated deity, buzzing black clouds cast shadows across countless fields in rural Ethiopia.

Coronavirus: South African Distell trying to curb hit from pandemic

Distell has toasted the performance of its Kenyan operations, while it is mulling the sale of two premium wine farms and other cost-reduction measures in South Africa as it grapples with COVID-19 restrictions.    

Coronavirus: Demolition of hotels in Rivers State illegal use of lockdown?

Many countries, including Nigeria, announced lockdowns to combat the coronavirus. Different states in Nigeria implemented their own policies.

Coronavirus: South Sudan’s Riek Machar latest victim of COVID-19

The South Sudanese Vice-President, Riek Machar, and his wife, Defence Minister Angelina Teny, will self-quarantine for the next two weeks, after testing positive for the coronavirus.

Coronavirus: Is WHO Chief Tedros Ghebreyesus on the chopping block?

When Dr Tedros Adhanom Ghebreyesus formally announced his candidacy for the post of the Director-General of the World Health Organization on 24 May 2016, he certainly received a mixed bag of interest and expectations.

Coronavirus: 3D print of ventilators, easy and cheap to produce says lead researcher

During this period of unprecedented strain on global healthcare systems, governments and hospitals are calling for solutions that will address the shortage of ventilators and other critical equipment to save lives during the pandemic.

COVID-19 is casting Magufuli in the worst light, in an election year

It began with Elizabeth Ane. President John Pombe Magufuli explained that he had suspected that the number of COVID-19 cases in Tanzania was being artificially inflated.

Burundi: WHO reps expelled ahead of polls set to go, despite COVID-19

Burundi expelled World Health Organisation (WHO) representatives in the country and warned election observers from the region that they would have to go into quarantine for 14 days upon arrival.

Nigeria VS Coronavirus: Cutting naira’s umbilical dependence on oil

The fragility of the reserves being used to support the naira and it's revalued rate shows that Nigeria needs to find new ways of earning foreign currency. In the first story of our series on the impact of COVID-19 on Nigeria, we look how its economy considers strategies to reduce the naira’s dependence on volatile oil prices.

We value your privacy

The Africa Report uses cookies to provide you with a quality user experience, measure audience, and provide you with personalized advertising. By continuing on The Africa Report, you agree to the use of cookies under the terms of our privacy policy.
You can change your preferences at any time.